Retail sale of pharmaceutical products
FOKUS APOTEK & BANDASJIST AS
Revenue 2024
NOK 7.2m
Operating profit
NOK −698,000
Equity
NOK −359,000
Incorporated
2023
Share capital
NOK 400,000
Key figures · 2024
Current ratio
0.93
Equity ratio
-12.8%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -9.7% | |
| Net margin (%%) | -10.5% | |
| Return on assets (%%) | -24.8% | |
| Likviditet | ||
| Current ratio | 0.93 | |
| Working capital | −196k | |
| Soliditet | ||
| Equity ratio (%%) | -12.8% | |
| Debt-to-equity ratio | -8.84 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.